Efficacy of Albuterol in the Treatment of Congenital Myasthenic Syndromes

Completed · Phase 1

Conditions studied: Congenital Myasthenic Syndrome

In brief

The study tests the notion that patients suffering from certain types of congenital myasthenic syndromes are benefitted by the use of Albuterol at doses used in clinical practice.

Key facts

Study ID

NCT01203592

Run by

Mayo Clinic

People needed

21

Starts

2010-09-01

Expected to finish

2013-08-01

Last updated by the study team

2016-01-01

Who can join

Age: 2 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Diagnosis of congenital myasthenic syndrome substantiated by typical clinical history, seronegativity to AChR and MuSK, and evidence of a decremental EMG response.

You may not qualify if…

• Uncontrolled hypertension, arrhythmias, or other significant cardiac disease.

Where it is running

• Mayo Clinic — Rochester, Minnesota, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.